Saxenda litigation — safety & injury con… | DrugsMonitor.com

Clinical summary and reported injury patterns for Saxenda litigation. Links to FDA recalls and litigation overview. Not medical advice.

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes.